Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Shinichi Oka, K. Tsuchiya et al.|Clinical Infectious Diseases|2007Cited by 222
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2Yosuke Maeda, Shuzo Matsushita|International Journal of Molecular Sciences|2024Cited by 6